RETACRIT 4000 [iU]/mL
epoetin alfa-epbx · INJECTION, SOLUTION · Pfizer Laboratories Div Pfizer Inc
RETACRIT is a injection, solution containing epoetin alfa-epbx at 4000 [iU]/mL, taken intravenous. Manufactured by Pfizer Laboratories Div Pfizer Inc.
Key Facts
- Brand Name
- RETACRIT
- Generic Name
- epoetin alfa-epbx
- NDC Code (Product)
0069-1307- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 4000 [iU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Marketing Status
- Application #
- BLA125545
- Marketing Start
- 06/18/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is RETACRIT used for?
RETACRIT contains epoetin alfa-epbx. It is a injection, solution taken intravenous. Consult your doctor for specific uses.
Is RETACRIT a controlled substance?
RETACRIT is not classified as a controlled substance by the DEA.
What is the generic name for RETACRIT?
The generic name for RETACRIT is epoetin alfa-epbx. There are no other listed brand versions of epoetin alfa-epbx.
What is the NDC code for RETACRIT 4000 [iU]/mL?
The NDC (National Drug Code) for RETACRIT 4000 [iU]/mL is 0069-1307, listed by Pfizer Laboratories Div Pfizer Inc.
Other RETACRIT Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)